Demyelination: The Role of Reactive Oxygen and Nitrogen Species
暂无分享,去创建一个
[1] D. Wink,et al. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. , 1998, Free radical biology & medicine.
[2] Joseph J. Volpe,et al. Maturation-Dependent Vulnerability of Oligodendrocytes to Oxidative Stress-Induced Death Caused by Glutathione Depletion , 1998, The Journal of Neuroscience.
[3] C. Coleclough,et al. Reciprocal stimulation between TNF-α and nitric oxide may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis , 1998, Journal of Neuroimmunology.
[4] W. Cowden,et al. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE , 1998, Journal of Neuroimmunology.
[5] R. Schmidt,et al. Peroxynitrite formation within the central nervous system in active multiple sclerosis , 1998, Journal of Neuroimmunology.
[6] K. Boje,et al. Nitric oxide and prostaglandin E2 formation parallels blood–brain barrier disruption in an experimental rat model of bacterial meningitis , 1998, Brain Research Bulletin.
[7] D. L. Wetzel,et al. Chemical analysis of multiple sclerosis lesions by FT-IR microspectroscopy. , 1998, Free radical biology & medicine.
[8] J. Zweier,et al. Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway. , 1998, Archives of biochemistry and biophysics.
[9] F. Abboud,et al. Nitric Oxide as an Autocrine Regulator of Sodium Currents in Baroreceptor Neurons , 1998, Neuron.
[10] S. LeVine,et al. Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice , 1998, Journal of Neuroimmunology.
[11] K. Frei,et al. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis , 1998, European Journal of Immunology.
[12] L. Hertz,et al. Peroxide‐scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress , 1998, Glia.
[13] J. Connor,et al. An in vitro model for analysis of oxidative death in primary mouse astrocytes , 1998, Brain Research.
[14] J. Weidner,et al. This information is current as Gene NOS 2 Exacerbated in Mice Lacking the Experimental Autoimmune Encephalomyelitis Is , 1998 .
[15] L. Ignarro,et al. Cutting Edge: Antisense Knockdown of Inducible Nitric Oxide Synthase Inhibits Induction of Experimental Autoimmune Encephalomyelitis in SJL/J Mice , 1998, The Journal of Immunology.
[16] D. Mattson,et al. Interferon-beta-1-b (IFN-B) decreases induced nitric oxide (NO) production by a human astrocytoma cell line , 1998, Journal of Neuroimmunology.
[17] C. Brosnan,et al. Selective inhibition of human glial inducible nitric oxide synthase by interferon‐β: Implications for multiple sclerosis , 1998, Annals of neurology.
[18] John C. Lee,et al. Extracellular Signal-Regulated Kinase and p38 Subgroups of Mitogen-Activated Protein Kinases Regulate Inducible Nitric Oxide Synthase and Tumor Necrosis Factor-α Gene Expression in Endotoxin-Stimulated Primary Glial Cultures , 1998, The Journal of Neuroscience.
[19] G. Giovannoni. Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis , 1998, Multiple sclerosis.
[20] H. Maeda,et al. Human Matrix Metalloprotease Activation by Insults of Bacterial Infection Involving Proteases and Free Radicals , 1998, Biological chemistry.
[21] D. Mattson,et al. Nerve conduction block by nitric oxide that is mediated by the axonal environment. , 1998, Journal of neurophysiology.
[22] A. Cellerino,et al. Free Radical Scavenging and Inhibition of Nitric Oxide Synthase Potentiates the Neurotrophic Effects of Brain-Derived Neurotrophic Factor on Axotomized Retinal Ganglion Cells In Vivo , 1998, The Journal of Neuroscience.
[23] A. Cross,et al. Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection , 1998, Journal of Neuroimmunology.
[24] G. Levi,et al. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide , 1998, Progress in Neurobiology.
[25] H. Koprowski,et al. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. Heales,et al. Pretreatment of Astrocytes with Interferon‐α/β Prevents Neuronal Mitochondrial Respiratory Chain Damage , 1998 .
[27] R. Murphy,et al. Free radicals in inflammatory neurological disease: Increased lipid peroxidation and haptoglobin levels in Guillain Barre syndrome , 1998, Irish journal of medical science.
[28] L. Ignarro,et al. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. , 1998, Journal of immunology.
[29] S. Heales,et al. Pretreatment of astrocytes with interferon-alpha/beta prevents neuronal mitochondrial respiratory chain damage. , 1998, Journal of neurochemistry.
[30] E. Pinteaux,et al. Distribution of mitochondrial manganese superoxide dismutase among rat glial cells in culture. , 1998, Glia.
[31] ichard,et al. AXONAL TRANSECTION IN THE LESIONS OF MULTIPLE SCLEROSIS , 1998 .
[32] B. Juurlink. Response of Glial Cells to Ischemia: Roles of Reactive Oxygen Species and Glutathione , 1997, Neuroscience & Biobehavioral Reviews.
[33] Y. Ando,et al. Changes in nitrite and nitrate (NO2 −/NO3 −) levels in cerebrospinal fluid of patients with multiple sclerosis , 1997, Journal of the Neurological Sciences.
[34] A. Cross,et al. Evidence for the production of peroxynitrite in inflammatory CNS demyelination , 1997, Journal of Neuroimmunology.
[35] S. Murphy,et al. Activated astrocytes induce nitric oxide synthase‐2 in cerebral endothelium via tumor necrosis factor α , 1997, Glia.
[36] M. Morganti-Kossmann,et al. Neurotransmitters in cerebrospinal fluid reflect pathological activity , 1997, European journal of clinical investigation.
[37] J. Merrill,et al. Inflammatory Events at the Blood Brain Barrier: Regulation of Adhesion Molecules, Cytokines, and Chemokines by Reactive Nitrogen and Oxygen Species , 1997, Brain, Behavior, and Immunity.
[38] A. Orlacchio,et al. Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis , 1997, Journal of Neuroimmunology.
[39] K. Smith,et al. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. , 1997, Brain : a journal of neurology.
[40] R. L. Cooper. Multiple sclerosis: an immune legacy? , 1997, Medical hypotheses.
[41] John X. Wilson,et al. Antioxidant defense of the brain: a role for astrocytes. , 1997, Canadian journal of physiology and pharmacology.
[42] R. Hughes,et al. A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis. , 1997, Brain : a journal of neurology.
[43] R. P. Kinkel,et al. Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis , 1997, Neurology.
[44] M. Grisham,et al. Effects of reactive metabolites of oxygen and nitrogen on gelatinase A activity. , 1997, The American journal of physiology.
[45] M. Mckinney,et al. Immunostimulation protects microglial cells from nitric oxide-mediated apoptosis. , 1997, Neuroreport.
[46] Kenneth J. Smith,et al. REVIEW ■ : Axonal Hyperexcitability: Mechanisms and Role in Symptom Production in Demyelinating Diseases , 1997 .
[47] M. Duchen,et al. Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system , 1997, Progress in Neurobiology.
[48] D. Hinton,et al. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation , 1997, Journal of Neuroimmunology.
[49] Steven M LeVine,et al. Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.
[50] W. Mcdonald,et al. Pretreatment of Astrocytes with Interferon‐α/β Impairs Interferon‐γ Induction of Nitric Oxide Synthase , 1997 .
[51] J M Land,et al. Nitric Oxide‐Mediated Mitochondrial Damage in the Brain: Mechanisms and Implications for Neurodegenerative Diseases , 1997, Journal of neurochemistry.
[52] D D Breimer,et al. The blood-brain barrier in neuroinflammatory diseases. , 1997, Pharmacological reviews.
[53] C. Lowenstein,et al. Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes , 1997, Journal of neuroscience research.
[54] I. Singh,et al. Modulation of Endogenous Antioxidant Enzymes by Nitric Oxide in Rat C6 Glial Cells , 1997 .
[55] G S Scott,et al. Reactive oxygen species in experimental allergic encephalomyelitis. , 1997, Biochemical Society transactions.
[56] S. Schwab,et al. Suppression of the oxidative burst in murine microglia by nitric oxide , 1997, Neuroscience Letters.
[57] Y. Vodovotz,et al. Superoxide Modulates the Oxidation and Nitrosation of Thiols by Nitric Oxide-derived Reactive Intermediates , 1997, The Journal of Biological Chemistry.
[58] G. Tocco,et al. Prevention and suppression of autoimmune encephalomyelitis by EUK-8, a synthetic catalytic scavenger of oxygen-reactive metabolites. , 1997, Cellular immunology.
[59] G. FitzGerald,et al. Urinary 8-EPI PGF2α: an index of oxidant stress in vivo* , 1997 .
[60] Y.-G. Li,et al. Slow sodium-dependent potential oscillations contribute to ectopic firing in mammalian demyelinated axons. , 1997, Brain : a journal of neurology.
[61] O. Bagasra,et al. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[62] R. Sobel,et al. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. , 1997, Journal of immunology.
[63] D. Grzybicki,et al. Nitric oxide synthase Type II expression by different cell types in MHV-JHM encephalitis suggests distinct roles for nitric oxide in acute versus persistent virus infection , 1997, Journal of Neuroimmunology.
[64] A. van Dam,et al. Inhibition of endotoxin‐induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: A role for transforming growth factor β , 1997 .
[65] J. Merrill,et al. The role of nitric oxide in multiple sclerosis , 1997, Journal of Molecular Medicine.
[66] G. Levi,et al. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors , 1997, Glia.
[67] G. Juhász,et al. Amino acid concentrations in cerebrospinal fluid of patients with multiple sclerosis , 1997, Acta neurologica Scandinavica.
[68] C. D. DE GROOT,et al. Immunocytochemical Characterization of the Expression of Inducible and Constitutive Isoforms of Nitric Oxide Synthase in Demyelinating Multiple Sclerosis Lesions , 1997, Journal of neuropathology and experimental neurology.
[69] S. Baig,et al. Neurotoxicity and possible roles of aspartic acid, glutamic acid and GABA in some neurologic disorders , 1997 .
[70] K. Scharffetter-Kochanek,et al. Hydrogen peroxide (H2O2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. , 1997, Free radical biology & medicine.
[71] W. Mcdonald,et al. Pretreatment of astrocytes with interferon-alpha/beta impairs interferon-gamma induction of nitric oxide synthase. , 1997, Journal of neurochemistry.
[72] C. Szabó. Physiological and pathophysiological roles of nitric oxide in the central nervous system , 1996, Brain Research Bulletin.
[73] A. Cross,et al. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis , 1996, Journal of Neuroimmunology.
[74] G. Kroemer,et al. Mitochondrial permeability transition triggers lymphocyte apoptosis. , 1996, Journal of immunology.
[75] J S Beckman,et al. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.
[76] D. Wink,et al. Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage. , 1996, Carcinogenesis.
[77] C. Brosnan,et al. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1beta and IL-1 receptor antagonist. , 1996, Journal of immunology.
[78] H. Link,et al. The cerebrospinal fluid from patients with multiple sclerosis promotes neuronal and oligodendrocyte damage by delayed production of nitric oxide in vitro , 1996, Journal of the Neurological Sciences.
[79] H. Sontheimer,et al. Cytokine modulation of glial glutamate uptake: a possble involvement of nitric oxide , 1996, Neuroreport.
[80] N. Janabi,et al. Endogenous nitric oxide activates prostaglandin F2 alpha production in human microglial cells but not in astrocytes: a study of interactions between eicosanoids, nitric oxide, and superoxide anion (O2-) regulatory pathways. , 1996, Journal of immunology.
[81] B. Juurlink,et al. Low Glutathione and High Iron Govern the Susceptibility of Oligodendroglial Precursors to Oxidative Stress , 1996, Journal of neurochemistry.
[82] S. Back,et al. Cystine Deprivation Induces Oligodendroglial Death: Rescue by Free Radical Scavengers and by a Diffusible Glial Factor , 1996, Journal of neurochemistry.
[83] M. Aschner. The functional significance of brain metallothioneins , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[84] S. Snyder,et al. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[85] J. Bockaert,et al. Effects of nitric oxide on glutamate-gated channels and other ionic channels , 1996, Journal of Chemical Neuroanatomy.
[86] J. Neal,et al. Immunocytochemically detectable metallothionein is expressed by astrocytes in the ischaemic human brain , 1996, Neuropathology and applied neurobiology.
[87] R. J. Waugh,et al. Mass spectrometric analysis of four regioisomers of F2-isoprostanes formed by free radical oxidation of arachidonic acid , 1996, Journal of the American Society for Mass Spectrometry.
[88] C. Colton,et al. Species differences in the generation of reactive oxygen species by microglia , 1996, Molecular and chemical neuropathology.
[89] John X. Wilson,et al. Osmotic Swelling Stimulates Ascorbate Efflux from Cerebral Astrocytes , 1996, Journal of neurochemistry.
[90] S. Linden,et al. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors , 1996, Clinical and experimental immunology.
[91] S. Barnes,et al. Peroxynitrite-dependent tryptophan nitration. , 1996, Chemical research in toxicology.
[92] H. Hartung,et al. Secretion of nitrite by Schwann cells and its effect on T-cell activation in vitro. , 1996, Cellular immunology.
[93] A. Compston,et al. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. , 1996, Brain : a journal of neurology.
[94] M. Mcdaniel,et al. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase , 1996, Journal of Neuroimmunology.
[95] T. Olsson,et al. Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. , 1996, Brain : a journal of neurology.
[96] S. Baig,et al. Multiple sclerosis and neurotransmission , 1996 .
[97] C. Szabó,et al. DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. , 1996, Free radical biology & medicine.
[98] F. J. Romero. Antioxidants in peripheral nerve. , 1996, Free radical biology & medicine.
[99] D. Muller,et al. Lipid peroxidation in neural tissues and fractions from vitamin E-deficient rats. , 1996, Free radical biology & medicine.
[100] M. Reilly,et al. 8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. , 1996, British journal of clinical pharmacology.
[101] E. Kinnunen. [Beta interferon and multiple sclerosis]. , 1996, Duodecim; laaketieteellinen aikakauskirja.
[102] T. Dawson,et al. Neurobiology of nitric oxide. , 1996, Critical reviews in neurobiology.
[103] J. Bolaños,et al. Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. , 1996, Free radical biology & medicine.
[104] J. Beckman,et al. The importance of superoxide in nitric oxide-dependent toxicity: evidence for peroxynitrite-mediated injury. , 1996, Advances in experimental medicine and biology.
[105] O. Bagasra,et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[106] S. Chandler,et al. Matrix metalloproteinases degrade myelin basic protein , 1995, Neuroscience Letters.
[107] Shuxian Hu,et al. Differential regulation by cytokines of human astrocyte nitric oxide production , 1995, Glia.
[108] M. D. Mossalayi,et al. Nitric oxide production by human monocytes: evidence for a role of CD23. , 1995, Immunology today.
[109] M. Colasanti,et al. Human ramified microglial cells produce nitric oxide upon Escherichia coli lipopolysaccharide and tumor necrosis factor α stimulation , 1995, Neuroscience Letters.
[110] B. Juurlink,et al. Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species , 1995, Brain Research.
[111] D. Grzybicki,et al. Activation of Astrocytes in the Spinal Cord of Mice Chronically Infected with a Neurotropic Coronavirus , 1995, Virology.
[112] S. Sakoda,et al. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis , 1995, Journal of Neuroimmunology.
[113] L. A. Hansen,et al. Suppression of hyperacute and passively transferred experimental autoimmune encephalomyelitis by the anti-oxidant, butylated hydroxyanisole , 1995, Journal of Neuroimmunology.
[114] Sean Murphy,et al. Expression of Inducible Nitric Oxide Synthase in Cerebral Endothelial Cells Is Regulated by Cytokine‐Activated Astrocytes , 1995, Journal of neurochemistry.
[115] M. Ikeda,et al. Cyclic guanosine monophosphate (cGMP), nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and Guillain-Barré syndrome. , 1995, Internal medicine.
[116] G. Kroemer,et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death , 1995, The Journal of experimental medicine.
[117] J. Bolaños,et al. Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration , 1995, Neuroscience Letters.
[118] Keij Suzuki,et al. Immunochemical detection of metallothionein in brain , 1995, Neurochemistry International.
[119] G. Andrews,et al. Temporalspatial patterns of expression of metallothionein-I and -III and other stress related genes in rat brain after kainic acid-induced seizures , 1995, Neurochemistry International.
[120] M. Geffard,et al. Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine , 1995, Journal of Neuroimmunology.
[121] P. Iversen,et al. Expression and regulation of brain metallothionein , 1995, Neurochemistry International.
[122] J. Wilson,et al. Ascorbate Transport and Intracellular Concentration in Cerebral Astrocytes , 1995, Journal of neurochemistry.
[123] H. Koprowski,et al. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[124] E. Bongarzone,et al. Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species , 1995, Journal of neuroscience research.
[125] H. Kolb,et al. Suppression of nitric oxide toxicity in islet cells by α‐tocopherol , 1995 .
[126] S. Hirai,et al. Activated microglia cause superoxide-mediated release of iron from ferritin , 1995, Neuroscience Letters.
[127] C. Raine,et al. The adhesion molecule and cytokine profile of multiple sclerosis lesions , 1995, Annals of neurology.
[128] T. Billiar. Nitric Oxide Novel Biology with Clinical Relevance , 1995, Annals of surgery.
[129] H. Hartung,et al. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis , 1995, Journal of Neuroimmunology.
[130] H. Vinters,et al. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes , 1995, Neuroscience.
[131] F. Hofmann,et al. Functional consequences of sulfhydryl modification in the pore-forming subunits of cardiovascular Ca2+ and Na+ channels. , 1995, Circulation research.
[132] F. Abboud,et al. Modulation of baroreceptor activity by nitric oxide and S-nitrosocysteine. , 1995, Circulation research.
[133] C. Piantadosi,et al. Hydroxyl radical production in the brain after CO hypoxia in rats. , 1995, Free radical biology & medicine.
[134] Christine D. Dijkstra,et al. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats , 1995, Journal of Neuroimmunology.
[135] H. Reichmann,et al. Inhibition of brain macrophage/microglial respiratory chain enzyme activity in experimental autoimmune encephalomyelitis of the Lewis rat , 1995, Neuroscience Letters.
[136] S. Snyder,et al. Neuroprotective effects of gangliosides may involve inhibition of nitric oxide synthase , 1995, Annals of neurology.
[137] J. Bolaños,et al. Evidence for increased nitric oxide production in multiple sclerosis. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[138] C. Colton. Induction of nitric oxide in cultured microglia: evidence for a cytoprotective role. , 1995, Advances in neuroimmunology.
[139] H. Kolb,et al. Suppression of nitric oxide toxicity in islet cells by alpha-tocopherol. , 1995, FEBS letters.
[140] J Garthwaite,et al. Nitric oxide signaling in the central nervous system. , 1995, Annual review of physiology.
[141] C. Rice-Evans,et al. Chapter 5 – Formation of free radicals and mechanisms of action in normal biochemical processes and pathological states , 1994 .
[142] L. Steinman,et al. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. , 1994, The Journal of clinical investigation.
[143] D. Hanley,et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains , 1994, Annals of neurology.
[144] C. Colton,et al. Induction of Superoxide Anion and Nitric Oxide Production in Cultured Microglia a , 1994, Annals of the New York Academy of Sciences.
[145] S. Barnes,et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. , 1994, The Journal of biological chemistry.
[146] G. F. Weber. The pathophysiology of reactive oxygen intermediates in the central nervous system. , 1994, Medical hypotheses.
[147] M. Jensen,et al. Prostaglandins and inhibitors of arachidonate metabolism suppress experimental allergic encephalomyelitis , 1994, Journal of Neuroimmunology.
[148] J. Bolaños,et al. Nitric Oxide‐Mediated Inhibition of the Mitochondrial Respiratory Chain in Cultured Astrocytes , 1994, Journal of neurochemistry.
[149] T. Olsson,et al. Increased transforming growth factor‐β, interleukin‐4, and interferon‐γ in multiple sclerosis , 1994, Annals of neurology.
[150] M. Noble,et al. N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[151] L. Ignarro,et al. Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cellsin vitro , 1994, Neuroscience.
[152] J. Springfield,et al. Pitfalls in the use of breath pentane measurements to assess lipid peroxidation. , 1994, Journal of lipid research.
[153] S. Hirai,et al. Detection of Superoxide Production by Activated Microglia Using a Sensitive and Specific Chemiluminescence Assay and Microglia‐Mediated PC12h Cell Death , 1994, Journal of neurochemistry.
[154] D. Troost,et al. Localization of metallothionein in the mammalian central nervous system. , 1994, Biological signals.
[155] S. Murphy,et al. Nitric oxide limits transcriptional induction of nitric oxide synthase in CNS glial cells. , 1994, Biochemical and biophysical research communications.
[156] C. Colton,et al. K+ modulation of microglial superoxide production: involvement of voltage-gated Ca2+ channels. , 1994, The American journal of physiology.
[157] A. Cross,et al. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. , 1994, The Journal of clinical investigation.
[158] C. Nathan,et al. Regulation of biosynthesis of nitric oxide. , 1994, The Journal of biological chemistry.
[159] R. Cohen,et al. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle , 1994, Nature.
[160] A. Taylor-Robinson,et al. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells , 1994, European journal of immunology.
[161] J. Newcombe,et al. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis , 1994, Neuropathology and applied neurobiology.
[162] J. Antel,et al. Astrocytes and catalase prevent the toxicity of catecholamines to oligodendrocytes , 1994, Brain Research.
[163] W. Brück,et al. Oligodendrocytes in the early course of multiple sclerosis , 1994, Annals of neurology.
[164] J. Connor,et al. Iron acquisition and expression of iron regulatory proteins in the developing brain: manipulation by ethanol exposure, iron deprivation and cellular dysfunction. , 1994, Developmental neuroscience.
[165] A. Casadevall,et al. Reactive nitrogen intermediates in human neuropathology: an overview. , 1994, Developmental neuroscience.
[166] S. McGorray,et al. Conjugated deferoxamine reduces blood-brain barrier disruption in experimental optic neuritis. , 1994, Ophthalmic research.
[167] V. Calabrese,et al. Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis. , 1994, International journal of clinical pharmacology research.
[168] J. Chen,et al. Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. , 1994, Progress in brain research.
[169] Kenneth J. Smith. Conduction properties of central demyelinated and remyelinated axons, and their relation to symptom production in demyelinating disorders , 1994, Eye.
[170] R. Gopalakrishna,et al. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. , 1993, The Journal of biological chemistry.
[171] M. Mcdaniel,et al. Interferon-γ and interleukin-1β induce nitric oxide formation from primary mouse astrocytes , 1993, Neuroscience Letters.
[172] K. Miura,et al. Maintenance of Neuronal Glutathione by Glial Cells , 1993, Journal of neurochemistry.
[173] James B. Mitchell,et al. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[174] G. Opdenakker,et al. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein , 1993, Journal of neuroscience research.
[175] W. Halliday,et al. Infrared spectroscopic characterisation of multiple sclerosis plaques in the human central nervous system. , 1993, Biochimica et biophysica acta.
[176] Balaraman Kalyanaraman,et al. Peroxynitrite modification of low‐density lipoprotein leads to recognition by the macrophage scavenger receptor , 1993, FEBS letters.
[177] G. Bartosz,et al. Increased generation of superoxide radicals in the blood of MS patients , 1993, Acta neurologica Scandinavica.
[178] L. Ignarro,et al. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. , 1993, Journal of immunology.
[179] C. Hutter. On the causes of multiple sclerosis. , 1993, Medical hypotheses.
[180] W. Fiers,et al. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene‐inductive effects of TNF. , 1993, The EMBO journal.
[181] Y. Vodovotz,et al. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta , 1993, The Journal of experimental medicine.
[182] A. Cross,et al. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study , 1993, The Journal of experimental medicine.
[183] S. Murphy,et al. Cytokines Regulate L‐Arginine‐Dependent Cyclic GMP Production in Rat Glial Cells , 1993, The European journal of neuroscience.
[184] H. Hartung,et al. Tumor necrosis factor-α in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system , 1993, Journal of Neuroimmunology.
[185] S. Bondy,et al. The relationship between excitotoxicity and oxidative stress in the central nervous system. , 1993, Free radical biology & medicine.
[186] D. Troost,et al. Distribution of metallothionein in the human central nervous system , 1993, Glia.
[187] C. Raine,et al. Multiple Sclerosis: Remyelination in Acute Lesions , 1993, Journal of neuropathology and experimental neurology.
[188] J. Volpe,et al. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[189] L. Rorke,et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[190] C. Damais,et al. IL1 and TNFα induce cGMP formation in C6 astrocytoma cells via the nitridergic pathway , 1993, Brain Research.
[191] G. Nisticó,et al. Cytokine-induced nitric oxide generation by cultured astrocytoma cells involves Ca(++)-calmodulin-independent NO-synthase. , 1993, Biochemical and biophysical research communications.
[192] J. Sawada,et al. Induction of metallothionein in a human astrocytoma cell line by interleukin‐1 and heavy metals , 1993, FEBS letters.
[193] E. Cho,et al. Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions , 1993 .
[194] D. Kirschner,et al. Thioridazine induces lipid peroxidation in myelin of rat brain , 1993, Neuropharmacology.
[195] S. Baig,et al. Role of neurotransmitter amino acids in multiple sclerosis in exacerbation, remission and chronic progressive course , 1993 .
[196] E. Cho,et al. Multiple sclerosis: remyelination of nascent lesions. , 1993, Annals of neurology.
[197] M. Mcdaniel,et al. Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes. , 1993, Neuroscience letters.
[198] J. Guy,et al. Role of hydrogen peroxide in experimental optic neuritis. A serial quantitative ultrastructural study. , 1993, Ophthalmic research.
[199] C. Damais,et al. IL1 and TNF alpha induce cGMP formation in C6 astrocytoma cells via the nitridergic pathway. , 1993, Brain research.
[200] S. Padmaja,et al. The reaction of no with superoxide. , 1993, Free radical research communications.
[201] H. Hartung,et al. Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. , 1993, Journal of neuroimmunology.
[202] M. L. Knapp,et al. Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions. , 1992, Clinical chemistry.
[203] J S Beckman,et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. , 1992, Archives of biochemistry and biophysics.
[204] A. Sher,et al. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[205] M. Simmons,et al. Induction of Nitric Oxide Synthase in Glial Cells , 1992, Journal of neurochemistry.
[206] S. Abramson,et al. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. , 1992, The Journal of clinical investigation.
[207] K. Boje,et al. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death , 1992, Brain Research.
[208] H. Hartung,et al. Production of nitrite by neonatal rat microglial cells/brain macrophages. , 1992, Cellular immunology.
[209] J. Merrill,et al. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[210] I. Rowland,et al. Inhibition of the reactive proliferation of lymphocytes by activated macrophages: the role of nitric oxide , 1992, Clinical and experimental immunology.
[211] E. Hall. Novel inhibitors of iron‐dependent lipid peroxidation for neurodegenerative disorders , 1992, Annals of neurology.
[212] R. Wanders,et al. Biochemistry of peroxisomes. , 1992, Annual review of biochemistry.
[213] J. Newcombe,et al. Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis. , 1992, European neurology.
[214] J. Stamler,et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[215] B E Kendall,et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. , 1991, Brain : a journal of neurology.
[216] T. Cebula,et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. , 1991, Science.
[217] Sherman Mp,et al. Cytokine- and Pneumocystis carinii- induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. , 1991 .
[218] S. Corradin,et al. Phagocytosis enhances murine macrophage activation by interferon‐γ and tumor necrosis factor‐α , 1991 .
[219] A. Bast,et al. Oxidants and antioxidants: state of the art. , 1991, The American journal of medicine.
[220] B. Freeman,et al. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. , 1991, Archives of biochemistry and biophysics.
[221] W. Mcdonald,et al. The longstanding MS lesion. A quantitative MRI and electron microscopic study. , 1991, Brain : a journal of neurology.
[222] P. Kubes,et al. Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[223] T. Billiar,et al. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. , 1991, The American journal of physiology.
[224] Seung U. Kim,et al. Oligodendroglial cell death induced by oxygen radicals and its protection by catalase , 1991, Journal of neuroscience research.
[225] T. Nozaki,et al. Trypanosoma cruzi: flow cytometric analysis of developmental stage differences in DNA. , 1991, The Journal of protozoology.
[226] B. Freeman,et al. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. , 1991, The Journal of biological chemistry.
[227] C. Brosnan,et al. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.
[228] H. Gruchow,et al. Treatment of multiple sclerosis with hyperbaric oxygen. Results of a national registry. , 1991, Archives of neurology.
[229] N. Otaki,et al. [44] Detection of metallothionein in brain , 1991 .
[230] N. Otaki,et al. Detection of metallothionein in brain. , 1991, Methods in enzymology.
[231] M. Sherman,et al. Cytokine- and Pneumocystis carinii- induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. , 1991, The Journal of protozoology.
[232] S. Corradin,et al. Phagocytosis enhances murine macrophage activation by interferon-gamma and tumor necrosis factor-alpha. , 1991, European journal of immunology.
[233] J. Connor,et al. Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains , 1990, Journal of neuroscience research.
[234] S. Thom,et al. Carbon monoxide-mediated brain lipid peroxidation in the rat. , 1990, Journal of applied physiology.
[235] R. Stocker,et al. Selective degeneration of oligodendrocytes mediated by reactive oxygen species. , 1990, Free radical research communications.
[236] M. Cuzner,et al. Fc receptor density, MHC antigen expression and superoxide production are increased in interferon-gamma-treated microglia isolated from adult rat brain. , 1989, Immunology.
[237] G. Wong,et al. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor , 1989, Cell.
[238] J. Merrill,et al. Tumor necrosis factor identified in multiple sclerosis brain , 1989, The Journal of experimental medicine.
[239] J. Connor,et al. Do oligodendrocytes mediate iron regulation in the human brain? , 1989, Annals of neurology.
[240] E. Hall,et al. Inhibition of arachidonic acid-induced vasogenic brain edema by the non-glucocorticoid 21-aminosteroid U74006F , 1988, Brain Research.
[241] H. Hartung,et al. Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase , 1988, Annals of neurology.
[242] P. Lebon,et al. Interferon-γ and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions , 1988, Journal of the Neurological Sciences.
[243] P. Doherty,et al. Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogen , 1988, Journal of Neuroimmunology.
[244] P. Lebon,et al. Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions. , 1988, Journal of the neurological sciences.
[245] A. Slivka,et al. Histochemical evaluation of glutathione in brain , 1987, Brain Research.
[246] R. Fine,et al. Development of transferrin‐positive oligodendrocytes in the rat central nervous system , 1987, Journal of neuroscience research.
[247] J. Clausen,et al. Glutathione peroxidase activity, associated enzymes and substrates in blood cells from patients with multiple sclerosis--effects of antioxidant supplementation. , 2009, Acta pharmacologica et toxicologica.
[248] J. Haglin,et al. Hyperbaric oxygenation and erythrocyte antioxidant enzymes in multiple sclerosis patients , 1986, Acta neurologica Scandinavica.
[249] J. Gutteridge. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides , 1986, FEBS letters.
[250] R. Wiggins,et al. Effect of Reactive Oxygen Species on Myelin Membrane Proteins , 1985, Journal of neurochemistry.
[251] P. Doherty,et al. Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent , 1984, The Journal of experimental medicine.
[252] W. I. McDonald,et al. Spontaneous and evoked electrical discharges from a central demyelinating lesion , 1982, Journal of the Neurological Sciences.
[253] G. Ellison,et al. Abnormal glutamic acid metabolism in multiple sclerosis , 1980, Journal of the Neurological Sciences.
[254] C. Schauf,et al. Mechanical fragility of erythrocytes in multiple sclerosis , 1980, Neurology.
[255] J. Prineas,et al. Remyelination in multiple sclerosis , 1978, Annals of neurology.
[256] M. Ginsberg. Delayed neurological deterioration following hypoxia. , 1979, Advances in neurology.
[257] E. Holtzman,et al. Microperoxisomes in the central nervous system of the postnatal rat , 1978, Brain Research.
[258] C. Thuning,et al. Oxygen immunosuppression: modification of experimental allergic encephalomyelitis in rodents. , 1978, Journal of immunology.
[259] J. Clausen,et al. ERYTHROCYTE GLUTATHIONE PEROXIDASE DEFICIENCY IN MULTIPLE SCLEROSIS , 1977, Acta neurologica Scandinavica.
[260] D. Metcalf,et al. Cells in Culture , 1977 .
[261] M. Ginsberg,et al. Hypoxic-ischemic leukoencephalopathy in man. , 1976, Archives of neurology.
[262] E. J. Field,et al. Red blood cell fragility in multiple sclerosis. , 1967, British medical journal.